Differentiation-inducing agents stably convert human neuroblastoma I-type cells to neuroblastic (N) or nonneuronal (S) neural crest cells.
Ross
R A
RA
Fordham University, Bronx, NY 10458.
Spengler
B A
BA
Rettig
W J
WJ
Biedler
J L
JL
D000954:Antigens, Surface / Q000032:analysis; D015415:Biomarkers; D015152:Blotting, Northern; D001973:Bromodeoxyuridine / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects; D002461:Cell Line, Transformed; D006801:Humans; D009432:Neural Crest / Q000473:pathology*; D009447:Neuroblastoma / Q000473:pathology*; D010641:Phenotype; D016271:Proto-Oncogene Proteins c-myc / Q000378:metabolism; D014212:Tretinoin / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D000954:Antigens, Surface; D015415:Biomarkers; D016271:Proto-Oncogene Proteins c-myc; D014212:Tretinoin; D001973:Bromodeoxyuridine